European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta ... ageing asthma and COPD inhaler Advair, which finally succumbed to generic competition in ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

like Breztri or Trelegy Ellipta). This group also includes SMART drugs like Symbicort (budesonide and formoterol fumarate dihydrate). Long-acting bronchodilators should not be used for an acute asthma ...

Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single-inhaler to combine a triple ... as the first Advair generic looks to be just around the corner, with the FDA already ...

Besides Ozempic and Wegovy, some of the other medications include Trelegy Ellipta, which treats asthma; Otezla, a psoriatic arthritis drug; and several that treat different forms of cancer.